Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension

European Journal of Clinical Investigation

Volumn 35, Issue 5, 2005, Pages 324-329

  Lim, H S ^a,b   Lip, G Y H ^a,b   Beevers, D G ^a,b   Blann, A D ^a,b  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Coronary heart disease; Diabetes; Hypertension; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 18744369909     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01495.x     Document Type: Article

References (26)

1. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 2001;24:447-53.
2. Haffher SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
3. Geneva S. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1 : Diagnosis and Classification of Diabetes Mellitus. WHO 1999.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffher SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-7.
6. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffher SM. San Antonio Heart Study. The metabolic syndrome as predictor of type-2 diabetes: the San Antonio Heart Study. Diabetes Care 2003;26:3153-9.
7. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
9. Alexander CM, Landsman PB, Teutsch SM, Haffher SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003,289:2560-72.
11. The Expert Committee on the Diagnosis and Classification of Diabetes. Report of the expert committee on the diagnosis and classification of diabetes. Diabetes Care 2002;25:S5-S20.
12. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
13. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391-7.
14. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DSJ, Haffner SM et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9.
15. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Poulter N et al. Guidelines for management of hypertension: report of the third Working Party of the British Hypertension Society. J Hum Hypenens 1999;13:569-92.
16. Hiltunen L, Kivela SL, Laara E, Keinanen-Kiukaanniemi S. Progression of normal glucose tolerance to impaired glucose tolerance or diabetes in the elderly. Diabetes Res Clin Pract 1997;35:99-106.
17. Mykkanen L, Kuusisto J, Pyorala K, Laakso M, Haffner SM. Increased risk of non-insulin-dependent diabetes mellitus in elderly hypertensive subjects. J Hypenens 1994;12:1425-32.
18. de Vegt F, Dekker JM, Jager A, Hienkens E, Kosterise PJ, Stehouwer CD et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a dutch population. The Hoorn study. JAMA 2001;285:2109-13.
19. Bland JM, Airman DG. The odds ratio. Br Med J 2000;320:1468-9.
20. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentration on coronary heart disease risk in the Helsinki Heart Study: implications of treatment. Circulation 1992;85:37-45.
21. Depres JP, Lemieux I, Dagenais GR, Cantin B, Lamarch B. HDL cholesterol as a marker of coronary heart disease risk: the Québec Cardiovascular Study. Atherosclerosis 2000;153:263-72.
22. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-8.
23. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-29.
24. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-90.
25. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993,36:553-9.
26. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores. JAMA 2001;286:180-7.